Skip to main content

The German version of the Mini Suffering State Examination (MSSE) for people with advanced dementia living in nursing homes

Abstract

Background

The Mini Suffering State Examination (MSSE) has been explicitly recommended to assess suffering in dementia patients. This study aimed to develop a German version of the MSSE and assess its psychometric properties involving people with advanced dementia (PAD) in a nursing home setting.

Methods

The MSSE was translated into German, and 95 primary nurses administered it cross-sectionally to 124 PAD in Zurich, Switzerland. The psychometric properties of the German MSSE version were calculated for this population.

Results

The mean age of the PAD was 83.3 years (SD = 9.1, range = 55–102 years), and 98 of them (79.0%) were women. The Kuder-Richardson Formula 20 coefficient for the entire scale (0.58), the eight items relating to objective health conditions (0.39), and the professional and family estimation of the patient’s suffering (0.64) indicated low internal consistency. A confirmatory factor analysis indicated an unsatisfactory fit to a one-factor structure, with a comparative fit index and root mean square error of approximation of 0.71 and 0.08, respectively, and a Tucker–Lewis index of 0.64. The MSSE total score was significantly but moderately correlated with the total scores of the Symptom Management–End-of-Life with Dementia (SM-EOLD) scale (Pearson’s correlation coefficient (r) = -0.44; p < 0.05), the physical suffering scores (r = 0.41; p < 0.05), and the psychological suffering scores (r = 0.55; p < 0.05).

Conclusions

The German version of the MSSE questionnaire did not perform well in the nursing home setting involving PAD. The instrument had low internal consistency, doubtful validity, and could not discriminate between suffering and other distressing symptoms. We do not recommend its use in this population.

Peer Review reports

Background

People with advanced dementia (PAD) experience an increase in burdensome symptoms, such as pain, agitation, shortness of breath [1,2,3], and high levels of physical, psychological, and existential or spiritual suffering toward the end of life [4, 5]. Pain and other distressing symptoms are not synonymous with suffering; they are phenomenologically distinct [6]. For a holistic approach to caring for PAD, it is essential to systematically discriminate between suffering and other distressing symptoms [6, 7].

Suffering is a complex, difficult-to-assess phenomenon. Consequently, self-reporting is the most reliable method for determining its intensity and magnitude [8]. As cognitive and verbal communication abilities in PAD tend to be severely impaired [9, 10], suffering must be assessed by proxy respondents, a fair substitute in nursing home settings [11].

The Mini Suffering State Examination (MSSE) scale was specifically developed to assess suffering in dementia patients at the end-of-life stage [12]. It has been explicitly recommended to measure the quality of dying in populations with dementia and in mixed long-term care populations in nursing or residential care home settings [13]. The instrument’s developers suggested that it has performed well with people with “end-stage dementia” in Israel [12, 14]. Another study maintained that there is a valid Dutch MSSE version available and that it performed well when used to measure the quality of dying among long-term care residents with dementia at the end-of-life stage [15]. However, the study cited by the authors as a reference for a valid Dutch MSSE version [16] only translated the MSSE into Dutch but did not assess the reliability and validity of the scores produced by this instrument.

A recent review of various suffering measurement instruments revealed that the study’s methodological quality in assessing the validity of the original English version of the MSSE questionnaire was doubtful and that the quality of the evidence was moderate [17]. The MSSE questionnaire used in the development cohort in Israel [12] produced inadequate internal consistency and doubtful reliability and criterion validity [17]. In addition, no assessment of unidimensionality was carried out by using confirmatory factor analysis (CFA) as recommended by Streiner [18]. Thus, it is unclear if the MSSE measures the construct of suffering as intended.

A study assessing the modified Spanish MSSE version suggested that content validity was acceptable and internal consistency moderate when used to measure suffering among patients with advanced cancer [19]. However, the MSSE was initially developed to assess suffering among patients with end-stage dementia, and the results of the Spanish study are not directly transferable to this population. Also, the questionnaire was administered one to six months after the patient’s death which might have led to recall bias. In addition, the authors did not assess structural validity by conducting a confirmatory factor analysis (CFA). Hence, it is difficult to judge if the Spanish version measures the construct of suffering as supposed.

Another recent systematic review and narrative synthesis [20] criticized the selection criteria used for the development cohort. The MSSE developers combined the Functional Assessment Screening (FAS) Tool stage 7c [21] and the Mini-Mental State Examination (MMSE) score of 0/30 [22]. The authors of the review argue that the MMSE (which is not a dementia staging tool but a screening tool for possible cognitive impairment [23]) shows a floor effect when used in advanced dementia. Hence, the MMSE may not be appropriate for assessing cognition at the end of life in dementia, as it subsumes all presentations of severe dementia into a zero score. On the other hand, the FAS categorizes end of life in advanced dementia into five sub-stages (stages 7a to 7e) [24]. Yet, the FAS is not without its limitations. It assumes a sequential pattern of deterioration in people with dementia [25, 26] and, thus, does not account for the large heterogeneity in dementia trajectories [27].

Hence, different conceptual and methodological problems with the original MSSE version might have influenced the Dutch and Spanish versions. Nevertheless, the measurement properties of test scores are population- and situation-dependent [18]. A test may perform excellently in one context and poorly in another as the reliability and validity of the scores are influenced by the interaction between the test and the particular group completing it [28]. There is no extensively validated instrument in German to assess the level of suffering in PAD. This study aimed to translate and cross-culturally adapt the MSSE scale and assess the measurement properties of the German version in nursing homes.

Methods

Study population

The present study was part of the Zurich Life and Death with Advanced Dementia (ZULIDAD) study, the aim of which was to describe the situation of PAD dying in nursing homes [29]. It was a prospective, multi-perspective, observational study conducted in 11 nursing homes in the Zurich area of Switzerland: 10 municipal nursing homes and one privately managed nursing home specializing in dementia care (Sonnweid AG). Details of the recruitment process are available in the published study protocol [29]. The residents in the participating institutions were screened using the nursing homes’ Resident Assessment Instrument-Minimum Data Set (RAI-MDS) (Swiss version 2.0) databases [30]. The RAI tool was developed to provide a standardized and inter-disciplinary approach to care planning in long-term care settings. It consists of several modules, such as the MDS, which contains indicator elements, including disease diagnoses, health conditions, cognitive abilities, nutritional status, etc. Another element is the cognitive performance scale (CPS), which was developed from five MDS items (“comatose,” “short-term memory,” “cognitive skills for decision making,” “making self understood,” and “self performance”). The final CPS score ranges from 0–6, with higher scores indicating more severe cognitive impairment [23].

The inclusion criteria were a diagnosis of dementia (RAI-MDS items “Alzheimer’s disease” or “dementia other than Alzheimer’s disease”) and a CPS score of 5 or 6, which indicates severe impairment (“advanced dementia”) [23]. A CPS score of 5 is comparable to a Mini Mental State Examination (MMSE) score of 5 [31]. The exclusion criterion was cognitive impairment due to other conditions, such as a major stroke, tumor, or coma (RAI-MDS item “disease diagnoses”).

Of the 1,786 eligible nursing home residents, 410 (22.9%) met the inclusion criteria. Two of the 410 residents were not eligible due to other neurodegenerative diseases; 37 had no healthcare proxies to be contacted; and 15 died between the eligibility assessment and the start of the data collection. Altogether, 356 healthcare proxies (relatives and professionals) were contacted, with 126 (35.4%) consenting to participation.

Questionnaires and data collection

The MSSE consists of eight items relating to health conditions and two items relating to professional and family estimations of the patient’s suffering. Each item has a binary score of present (1) or not (0) (yes/no format). The final score ranges from 0–10 (0–3 corresponding to low, 4–6 to intermediate, and 7–10 to high levels of suffering) [12]. Since no manual exists for the MSSE, no specific rater training could be performed with the nurses. All nurses underwent a 60–90 min one-on-one introduction with a researcher covering the study questionnaire. Furthermore, researchers were available throughout the study for all questions regarding the questionnaire. Although the Kuder-Richardson Formula 20 (KR-20) is a relevant index to evaluate internal consistency in dichotomously scored scales such as the MSSE, the instrument developers reported Cronbach’s alpha reliability coefficient in the original English version of the MSSE as 0.735 and 0.718, respectively, for groups assessed by two physicians [12].

In addition to the MSSE, symptom management was assessed with the Symptom Management–End-of-Life with Dementia (SM-EOLD) scale [32] and global estimations of physical and psychological suffering, with two separate single items to test for construct validity. The SM-EOLD consists of nine items, including those relating to pain, shortness of breath, and fear, and is recommended for assessing nursing home residents with dementia [33]. Proxy respondents indicate how frequently they have observed the symptoms in the last four weeks on a six-step scale (“never,” “once a month,” “two or three times a month,” “once a week,” “two or three times a week,” or “daily”), with possible scores ranging from 0 to 45 and higher scores indicating better symptom management. Global physical and psychological suffering were assessed using two separate questions referring to the previous seven days on an 11-step scale ranging from 0 (no suffering) to 10 (highest possible suffering): “How would you rate the extent of the PAD’s physical suffering?” “How would you rate the extent of the PAD’s psychological suffering?”.

The MSSE, the SM-EOLD, and the two separate questions assessing global physical and psychological suffering were all administered by primary nurses. The primary nursing care system emphasizes person-centered delivery and assigns specific nurses to specific patients [34]. Due to the close relationship that primary nurses develop with their patients, they can be considered reasonably accurate observers of suffering in PAD.

Of the 126 PAD included in the ZULIDAD study, data for two of them were missing because their primary nurses did not carry out the baseline measurements. Thus, 124 PAD were assessed by 95 primary nurses. Among them, 72 were responsible for one PAD each and 23 for multiple PAD (17 primary nurses for two PAD each and six primary nurses for three PAD each). Of the 124 PAD, SM-EOLD scores were missing for 10 (8.05%) of them. Thus, SM-EOLD scores were available for 114 PAD. The global estimations of physical and psychological suffering were available for all 124 PAD. (All data presented in this article are from baseline measurements collected between December 2013 and December 2014. Permission was obtained from the original author of the MSSE (Dr Aminoff) and of the SM-EOLD (Dr Volicer) to use and translate the instruments for this study.)

German translation of the MSSE

The English version of the MSSE [12] was translated into German and cross-culturally adapted to the German context based on the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) guidelines [35]. Two researchers performed independent forward translations and reconciled them into one forward translation, which was back-translated by a native English speaker with a professional background in dementia care. All three translators reviewed the back-translation and harmonized the German version with it. Three experts reviewed the harmonized German version—a general practitioner, a senior long-term care nurse, and a family member of a PAD—for comprehensibility, relevance, face validity, and intertranslation validity and finalized it.

Psychometrical scale performance analysis

Scale development involves complex and systematic procedures grounded in theoretical and methodological rigor in relation to the measurement problem at hand. The theoretical model serves as a guide for conceptual formulations and the definition and operationalization of the phenomenon to be measured [36]. To assess whether the MSSE questionnaire matched the intended goals of the developers, we first analyzed the theoretical and conceptual framework of the MSSE questionnaire, how the latent construct of suffering was defined and operationalized, and whether the item generation was based on deduction, induction, or a combination of the two methods.

Clinically useful measures should exhibit minimal floor and ceiling effects, which are considered to be present when more than 15% of the persons assessed achieve the lowest or highest possible total score, respectively [37]. Consequently, patients with the lowest (0) or highest (10) possible total MSSE scores cannot be distinguished from each other concerning their level of suffering.

Structural validity was evaluated by confirmatory factor analysis (CFA) to assess whether the scores of the MSSE instrument would confirm the predefined unidimensionality of the construct of suffering [38]. We also conducted a Mokken scale analysis (MSA) [39] to assess the assumption of unidimensionality. The investigation of MSA models is suitable when the number of items in a questionnaire is low [40], as with the MSSE.

Construct validity—the degree to which the scores of an instrument are consistent with hypotheses based on the assumption that the instrument validly measures the intended construct—was assessed using convergent validity and divergent validity [41]. Convergent validity assesses how a scale correlates with related variables or other related measures, and divergent validity is an assessment of a scale’s lack of correlation with dissimilar variables or unrelated measures [18].

For convergent validity, we hypothesized that good correlations between the total MSSE score and global estimations of physical and psychological suffering would be found. For divergent validity, we hypothesized that a weak correlation between the total MSSE score and the SM-EOLD total scores would be found.

Statistical analysis

All calculations were computed with STATA, version 16.1 for Mac [42]. Missing data were not imputed, and omitted items were excluded from the analysis. The measurement properties of the scores produced by the instruments were assessed using several indices [38, 43].

Descriptive analysis was used to calculate the mean scores (M) and standard deviations (SD) of the sociodemographic and clinical variables of PAD, the sociodemographic variables of the primary nurses, the MSSE total scores, the SM-EOLD total scores, and the two separate single items for the global estimations of physical and psychological suffering. Nominal data were reported as frequencies (numbers, percentages).

The internal consistency reliability of the dichotomously scored MSSE items was measured using the Kuder-Richardson Formula 20 (KR-20). A value of > 0.7 was expected [18, 44].

To assess structural validity, a CFA was used. Variation and covariation among the 10 items were evaluated using fit indices for a reflective one-factor structure model. We calculated the following fit indices: the root mean square error of approximation (RMSEA) with a 90% confidence interval (CI), the comparative fit index (CFI), and the Tucker–Lewis index (TLI). Although cutoff rules are still under discussion, it has been suggested that a CFI of > 0.95 and an RMSEA of < 0.06 indicate an acceptable fit for binary variables [45]. TLI values close to 0.95 are considered to demonstrate an acceptable fit. A factor loading of > 0.5 was expected for each item. Scalability was measured using Loevinger’s coefficient H. By convention, the strength of a scale is considered weak (0.3 ≤ H < 0.4), moderate (0.4 ≤ H < 0.5), or strong (0.5 ≤ H ≤ 1.0) [40].

Convergent and discriminant validity were determined by analyzing Pearson’s correlation [38]. The size of the correlational effects is considered small (0.1 < Pearson’s correlation coefficient (r) < 0.3), moderate (0.3 < r < 0.5), or high (r > 0.5) [46]. The level of significance (p value) of < 0.05 (two-tailed test) was considered statistically significant.

Results

No significant problems occurred during the translation of the MSSE. Compared with the original English version, no items were deleted from or added to the German version. The expert panel assessed the items’ intents and linguistic and cultural nuances. Minor changes were made to the wording for better comprehensibility, harmonizing the new translation with the source version and ensuring linguistic and cultural relevance. Thus, the linguistic validity of the German version was confirmed (see Fig. 1).

Fig. 1
figure 1

German version of the Mini Suffering State Examination (MSSE) questionnaire

The developers of the original MSSE questionnaire asserted that the instrument’s conceptual model and theoretical framework were based on Cassel’s concept of suffering, which emphasizes its multidimensionality and threat to people’s integrity [47]. However, the instrument’s developers did not specify how Cassel’s definition of suffering was considered during the development of the original MSSE questionnaire, which theoretical model was used for item generation, why particular characteristics of suffering were chosen, and how they related to the target construct of suffering. Social, spiritual, and existential factors that are essential aspects of suffering as well as physical and psychological dimensions [6, 48] were omitted from the original MSSE questionnaire.

The mean age of the 124 PAD was 83.3 years (SD = 9.05, range = 55–102 years), and 98 of them were women (79.0%). Sixty-four PAD (51.6%) were diagnosed with Alzheimer’s disease, 56 (45.2%) with dementia other than Alzheimer’s disease, and four (3.2%) with both Alzheimer’s and dementia other than Alzheimer’s disease. All PAD had a CPS of 5, except two who had a CPS of 6, indicating that all PADs were severely impaired in their daily decision-making.

Of the 95 primary nurses involved in the evaluation process, 77 (81.1%) were women. The mean age was 45.1. Only three (3.2%) were certified in palliative care; 25 (26.3%) had external training in palliative care; 32 (33.7%) had internal training only; and 35 (36.8%) had no specific training in palliative care. The characteristics of the primary nurses, including their work experience in dementia care and the frequency of their contact with the PAD, are depicted in Table 1. The general characteristics of the German MSSE items are depicted in Table 2.

Table 1 Characteristics of primary nurses involved in the evaluation process (N = 95)
Table 2 Characteristics of the German MSSE items (N = 124)

Of the 124 PAD, 94 (75.8%) had a low level of suffering; 26 (21.0%) had an intermediate level of suffering; and 4 (3.2%) had a high level of suffering. The mean total MSSE score for the 124 PAD was 2.33 (SD = 1.77). The distribution of the total MSSE scores showed the existence of floor effects as the PADs were clustered at the low level of suffering (see Fig. 2).

Fig. 2
figure 2

Distribution of total scores of the German MSSE. Legend: N = 124, Mean scores = 2.33, Standard deviation = 1.77; Interpretation of total scores. Aminoff et al. 2004 [12]: 0–3(low level of suffering), 4–6 (intermediate level of suffering), 7–10 (high level of suffering)

The mean total SM-EOLD score for the 114 PAD was 21.91 (SD = 9.16, range = 0–40), 2.29 (SD = 1.80, range = 0–10) for physical suffering, and 3.19 (SD = 2.35, range = 0–8) for psychological suffering of 124 PAD.

The KR-20 coefficient for the entire sample was 0.58 (0.56 for women and 0.67 for men), 0.39 for the eight items relating to health conditions, and 0.64 for the professional and family estimation of the patient’s suffering, indicating low internal consistency reliability.

The CFA showed that the MSSE questionnaire had a low fit to the reflective one-factor structure model, with CFI = 0.71, RMSEA = 0.08, and TLI = 0.64. Figure 3 shows the reflective one-factor model of the German MSSE, with error terms e1–e10 and standardized parameter estimates. Seven of the 10 items underperformed. Only three items had a factor loading of 0.40 or above: pain (0.44), suffering according to medical opinion (0.77), and suffering according to family opinion (0.59).

Fig. 3
figure 3

The reflective one-factor model of the German MSSE with error terms e1–e10, and standardized parameter estimates

The level of response coherence to the questionnaire was weak to moderate for seven of the 10 items, as shown by the H values. More precisely, one item was unscalable (“invasive action”), and coherence was weak for four items (“malnutrition,” “eating disorders,” “unstable medical condition,” and “suffering according to family opinion”), moderate for three items (“pain,” “decubitus ulcers,” and “suffering according to medical opinion”), and strong for two items (“not calm,” and “screams”) (see Table 2).

The MSSE scores were moderately correlated with the SM-EOLD scores (r = -0.44; p < 0.05), the physical suffering scores (r = 0.41; p < 0.05), and the psychological suffering scores (r = 0.55; p < 0.05).

Discussion

The present study found that the original English version of the MSSE was based on inadequate theoretical and conceptual underpinnings and an incomplete construction process. Therefore, the MSSE is a poor reflection of the concept of suffering. The instrument could discriminate neither between the different levels of suffering nor between suffering and other distressing symptoms. The German version of the MSSE produced inconsistent and, therefore, incorrect data for PAD living in nursing homes. It had low internal consistency reliability and doubtful validity. Therefore, empirical evidence does not support the intended interpretation and use of the German MSSE scores for needs assessment and decision-making regarding the level of suffering of PAD in the nursing home context. Consequently, we do not recommend its use in this population and setting.

Our theoretical and methodological analysis revealed significant flaws in the scale development process of the original MSSE version, such as a lack of adequate conceptualization and operationalization of the construct of suffering and no assessment of content validity, a vital step in scale development [36]. The theoretical, conceptual, and methodological shortcomings led to confusion about the delimitation of the construct of suffering, including the similarities and differences between suffering and symptom management. These deficiencies weakened the measurement results gained from the original English version and that of the German one, compromising the future applicability of the scale and hindering its generalizability.

In our study, the clustering of PADs at the low level of suffering and the lack of PADs at the high level of suffering suggest that, based on the total scores on the MSSE questionnaire, the PADs could not be sufficiently discriminated from each other concerning their level of suffering. The instrument, therefore, had low discriminatory power.

The values of the KR-20 coefficients indicated low internal consistency reliability. The two subjective items relating to the professional and family estimations of the patient’s suffering had a higher KR-20 coefficient (0.64) than the eight objective items relating to the patient’s health conditions (0.39). These indicator variables appear to have been poorly chosen; thus, there is a need for new variables that are more reflective of the construct of suffering.

The low internal consistency reliability may also have been caused by the response format chosen by the instrument developers. Binary items are easy to answer, but a major shortcoming of binary responses is that each item can have only minimal variability, and any pair of items can only have one of two levels of covariation. With binary items, each item contributes little to the sum of all the elements in the covariance matrix for the individual items due to the limitations in possible variances and covariances. Thus, additional items are needed to obtain the same degree of scale variance if the items are binary [36].

Compared with the coefficient of internal consistency reliability of the total scores of the original version, the scores of the German version were lower, likely reflecting differences in the context and sample composition. Reliability estimates tend to be higher with more heterogeneous populations, which would be expected to have values across the entire range of a measure, as would occur with patients both with and without a condition [49]. In our study, the population was highly homogenous as all PAD had a CPS of 5, except two who had a CPS of 6. The studies conducted using the original English version did not adequately describe the study sample, hindering the interpretability of the scores produced. An in-depth comparison of the context and sample composition between the original English and German versions was impossible (see Table 3).

Table 3 Comparison of sample composition and setting of the original English version and the German version of the MSSE questionnaire

As research in cross-cultural gerontology demonstrates [50], different cultural and social contexts affect various phenomena related to aging and influence and shape study objectives and designs. Hence, the different reliability values may have also been caused by different socio-cultural and contextual factors in Israel and Switzerland, leading to variances of concepts and relevance statements about the construct of suffering and how to assess and measure it.

Another reason for the different reliability values may be the different inclusion criteria of the study sample. The inclusion criteria of the ZULIDAD study were a diagnosis of dementia (RAI-MDS items “Alzheimer’s disease” or “dementia other than Alzheimer’s disease”) and a CPS score of 5 or 6, which indicates severe impairment (“advanced dementia”) [23], whereas the instrument developers of the MSSE, as mentioned before in the “background” section, combined the FAS stage 7c [21] and the MMSE score 0/30 [22] (see Table 3).

The CFA showed that seven of the 10 items underperformed as the factor loadings were below 0.30. These items were considered inadequate as they contributed < 10% of the variation of the latent construct being measured. It is recommended that items with factor loadings of 0.40 and above be retained [49, 52]. Only the following three items seemed to be specified correctly: pain, suffering according to medical opinion, and suffering according to family opinion (see Fig. 3). CFA is extremely useful when comparing the original with a translated version of a scale through the use of factor loadings from the original as trial loadings in the second [18]. The instrument developers did not conduct a CFA of the original version and only reported an alpha value [12]. It is insufficient to report only on selected statistical properties of a new instrument and claim that it is reliable and valid. According to Streiner [18], several sources of evidence are required to build the case that the instrument measures what it is supposed and intended to measure. In our study, the MSA was carried out in addition to the CFA to permit further insights into the dimensionality of the MSSE scale. The H values also indicated that the scalability of the MSSE was unsatisfactory.

Compared with the construct validity of the original English version tested with the SM-EOLD scale (r = 0.57, p < 0.001) [53], the score of the German version was lower. Both global physical suffering and global psychological suffering were moderately correlated with the MSSE. Given the poor measurement properties of the German version of the MSSE, it was impossible to draw valid conclusions from these correlational effects.

Suffering is a complex phenomenon that cannot be easily grasped or measured. Given its many definitions, it is critical to apply specific definitions developed for certain contexts and particular purposes, such as certain types of research or care. Moreover, suffering is multidimensional: it can be influenced by physical and psychological, social, spiritual, and existential factors [6, 48]. As such, a methodologically sound assessment tool should also reflect multidimensional perspectives of suffering, an essential aspect of palliative care [54].

The Suffering Pictogram [55], for instance, is one such robust instrument that could be adopted and tailored to the situation of PAD. It is grounded in elaborate conceptual and theoretical underpinnings. First, the developers carried out a qualitative study among adult palliative care patients to assess their experience with suffering [56]. Based on a thematic network analysis of semi-structured interviews, they deduced the concept of the “suffering threshold,” defined as a unique, subjective, and dynamic point, influenced by various existential and experiential factors, where events and experiences are perceived as suffering. Their existential–experiential model of suffering emphasizes the complex interplay of various factors that inform the formation of suffering. Thus, the authors defined suffering as an unpleasant existential experience that occurs when the individual suffering threshold has been surpassed. Consequently, interventions that modulate the experiential dimension of suffering, in addition to treating unpleasant existential events, may mitigate suffering.

In subsequent research, the instrument developers conducted a validation study of the Suffering Pictogram with 91 palliative care patients [55]. This study found that the Suffering Pictogram was a brief, reliable, and valid instrument to measure experiential suffering in palliative care. A systematic review of instruments assessing suffering in palliative care identified the Suffering Pictogram as the most useful instrument [17]. It was the only measure in which the methodological quality was adequate for content validity, structural validity, internal consistency, and concurrent validity [55].

Although the Suffering Pictogram has only been tested among patients diagnosed with various forms of cancer with palliative care needs, we believe that a modified version of the instrument could be useful to PAD when adopted and tailored to their unique disease profiles, needs, and preferences. Traditionally, the palliative care approach has been associated with people suffering from cancer. Studies have shown that the conceptual foundations of a palliative care approach can be expanded to PAD because they can be considered patients with palliative care needs due to the chronic and life-limiting conditions of the illness [57, 58]. Such a modification of the instrument, which takes the unique condition and situation of PAD into account, requires the involvement of stakeholders, such as patients and their caregivers, researchers, clinicians, instrument developers, advocacy groups, or others, across different stages of the instrument development process. Studies about stakeholder involvement and palliative care have shown that the engagement of stakeholders in research improves the research process and promotes more patient-centered results [59].

Our study did have some limitations. It was based on data collected in 11 nursing homes in Zurich. Therefore, the results are not directly transferable to other settings. Since each PAD was evaluated by a single primary nurse, and given that a single measurement was conducted, we could not report inter-rater, intra-rater, or test–retest reliability. Different levels of education and work experience among the primary nurses may have influenced the administration of the MSSE questionnaire. In our sample, women outnumbered men, an overrepresentation that corresponds with the sex distribution of nursing home residents in Switzerland, three-quarters of whom are women [60].

Conclusion

We demonstrated that the German version of the MSSE questionnaire did not perform well in the nursing home setting involving PAD. Presumably, due to the insufficient conceptualization and operationalization of the construct of suffering in the original MSSE version, the instrument could discriminate neither between suffering and other distressing symptoms nor between different levels of suffering. Consequently, we do not recommend the use of this instrument in this particular population and setting.

Availability of data and materials

The data and materials that support the findings of this study are available from the corresponding author, NZ, upon reasonable request.

Abbreviations

CFA:

Confirmatory Factor Analysis

CFI:

Comparative Fit Index

CI:

Confidence Interval

CPS:

Cognitive Performance Scale

FAST:

Functional Assessment Staging

FIM:

Functional Independence Measure

ISPOR:

International Society for Pharmacoeconomics and Outcomes Research

KR-20:

Kuder-Richardson Formula 20

M:

Mean

MDS:

Minimum Data Set

MMSE:

Mini Mental State Examination

MSA:

Mokken Scale Analysis

MSSE:

Mini Suffering State Examination

RAI–MDS:

Resident Assessment Instrument–Minimum Data Set

RMSEA:

Root Mean Square Error of Approximation

PAD:

People with Advanced Dementia

SD:

Standard Deviation

SM-EOLD:

Symptom Management–End-of-Life with Dementia

TLI:

Tucker-Lewis Index

ZULIDAD:

Zurich Life and Death with Advanced Dementia

References

  1. Di Giulio P, Toscani F, Villani D, Brunelli C, Gentile S, Spadin P. Dying with advanced dementia in long-term care geriatric institutions: a retrospective study. J Palliat Med. 2008;11:1023–8. https://doi.org/10.1089/jpm.2008.0020.

    Article  PubMed  Google Scholar 

  2. Mitchell SL, Teno JM, Kiely DK, Shaffer ML, Jones RN, Prigerson HG, et al. The clinical course of advanced dementia. New Engl J Med. 2009;361:1529–38. https://doi.org/10.1056/NEJMoa0902234.

    CAS  Article  PubMed  Google Scholar 

  3. Hendriks SA, Smalbrugge M, Hertogh CMPM, van der Steen JT. Dying with Dementia: symptoms, treatment, and quality of life in the last week of life. J Pain Symptom Manage. 2014;47:710–20. https://doi.org/10.1016/j.jpainsymman.2013.05.015.

    Article  PubMed  Google Scholar 

  4. Schulz R, McGinnis KA, Zhang S, Martire LM, Hebert RS, Beach SR, et al. Dementia patient suffering and caregiver depression. Alz Dis Assoc Dis. 2008;22:170–6. https://doi.org/10.1097/WAD.0b013e31816653cc.

    Article  Google Scholar 

  5. Schulz R, Monin JK, Czaja SJ, Lingler JH, Beach SR, Martire LM, et al. Measuring the experience and perception of suffering. Gerontologist. 2010;50:774–84. https://doi.org/10.1093/geront/gnq033.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Cassell EJ. The nature of suffering and the goals of medicine. Oxford: Oxford University Press; 2004.

    Book  Google Scholar 

  7. Hardcastle VG. Pain, chronic pain, and suffering. In: Solomon M, Simon JR, Kincaid H, editors. The Routledge companion to philosophy of medicine. New York: Routledge; 2017. p. 124–33.

    Google Scholar 

  8. Cassell EJ. Recognizing suffering. Hastings Cent Rep. 1991;21:24–31. https://doi.org/10.2307/3563319.

    CAS  Article  PubMed  Google Scholar 

  9. Bayles KA, Tomoeda CK, Cruz RF, Mahendra N. Communication abilities of individuals with late-stage Alzheimer disease. Alz Dis Assoc Dis. 2000;14:176–81.

    CAS  Article  Google Scholar 

  10. Blair M, Marczinski CA, Davis-Faroque N, Kertesz A. A longitudinal study of language decline in Alzheimer’s disease and frontotemporal dementia. J Int Neuropsych Soc. 2007;13:237–45. https://doi.org/10.1017/S1355617707070269.

    Article  Google Scholar 

  11. Kutner JS, Bryant LL, Beaty BL, Fairclough DL. Symptom distress and quality-of-life assessment at the end of life: the role of proxy response. J Pain Symptom Manage. 2006;32:300–10. https://doi.org/10.1016/j.jpainsymman.2006.05.009.

    Article  PubMed  Google Scholar 

  12. Aminoff BZ, Purits E, Noy S, Adunsky A. Measuring the suffering of end-stage dementia: reliability and validity of the Mini-Suffering State Examination. Arch Gerontol Geriat. 2004;38:123–30. https://doi.org/10.1016/j.archger.2003.08.007.

    Article  Google Scholar 

  13. van Soest-Poortvliet MC, van der Steen JT, Zimmerman S, Cohen LW, Reed D, Achterberg WP, et al. Selecting the best instruments to measure quality of end-of-life care and quality of dying in long term care. J Am Med Dir Assoc. 2013;14:179–86. https://doi.org/10.1016/j.jamda.2012.09.019.

    Article  PubMed  Google Scholar 

  14. Aminoff BZ. Not calm and Aminoff Suffering Syndrome in advanced Alzheimer’s disease. Am J Alzheimers Dis. 2016;31:169–80. https://doi.org/10.1177/1533317515598858.

    Article  Google Scholar 

  15. van Soest-Poortvliet MC, van der Steen JT, Zimmerman S, Cohen LW, Klapwijk MS, Bezemer M, et al. Psychometric properties of instruments to measure the quality of end-of-life care and dying for long-term care residents with dementia. Qual Life Res. 2012;21:671–84. https://doi.org/10.1007/s11136-011-9978-4.

    Article  PubMed  Google Scholar 

  16. Schols R, Schipper R. De Mini Suffering State Exam (MSSE) onderzocht in een Nederlangs verpleeghuis [The Mini-Suffering State Exam (MSSE) has been studied in a Dutch nursing home]. Tijdschrift voor Verpleeghuisgeneeskunde. 2003;27:14–8.

    Google Scholar 

  17. Gutiérrez Sánchez D, Gómez-García R, Cuesta-Vargas AI, Pérez-Cruzado D. The suffering measurement instruments in palliative care: a systematic review of psychometric properties. Int J Nurs Stud. 2020;110:103704. https://doi.org/10.1016/j.ijnurstu.2020.103704.

    Article  PubMed  Google Scholar 

  18. Streiner DL, Norman GR, Cairney J. Health measurement scales: a practical guide to their development and use. Oxford: Oxford University Press; 2015.

    Book  Google Scholar 

  19. Gutiérrez-Sánchez D, Gómez-García R, López-Medina I, Cuesta-Vargas AI. Psychometric testing of the Spanish modified version of the Mini-Suffering State Examination. Int J Environ Res Public Health. 2021;18:7821. https://doi.org/10.3390/ijerph18157821.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Browne B, Kupeli N, Moore KJ, Sampson EL, Davies N. Defining end of life in dementia: a systematic review. Palliative Med. 2021:1–14. https://doi.org/10.1177/02692163211025457.

  21. Sclan SG, Reisberg B. Functional assessment staging (FAST) in Alzheimer’s disease: reliability, validity, and ordinality. Int Psychogeriatr. 1992;4:55–69. https://doi.org/10.1017/s1041610292001157.

    Article  PubMed  Google Scholar 

  22. Folstein MF, Folstein SE, McHugh PR. „Mini-Mental State:“ a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98. https://doi.org/10.1016/0022-3956(75)90026-6.

    CAS  Article  PubMed  Google Scholar 

  23. Morris JN, Fries BE, Mehr DR, Hawes C, Phillips C, Mor V, et al. MDS Cognitive Performance Scale©. J Gerentol. 1994;49:M174–82. https://doi.org/10.1093/geronj/49.4.M174.

    CAS  Article  Google Scholar 

  24. Reisberg B, Jamil IA, Khan S, Monteiro I, Torossian C, Ferris S, et al. Staging dementia. In: Abou-Saleh MT, Katona CLE, Kumar A, editors., et al., Principles and practice of geriatric psychiatry. 3rd ed. Chichester: John Wiley & Sons; 2011. p. 162–9.

    Google Scholar 

  25. Luchins DJ, Hanrahan P, Murphy K. Criteria for enrolling dementia patients in hospice. J Am Geriatr Soc. 1997;45:1054–9. https://doi.org/10.1111/j.1532-5415.1997.tb05966.x.

    CAS  Article  PubMed  Google Scholar 

  26. Reisberg B, Ferris SH, Franssen EH, Shulman E, Monteiro I, Sclan SG, et al. Mortality and temporal course of probable Alzheimer’s disease: a 5-year prospective study. Int Psychogeriatr. 1996;8:291–311. https://doi.org/10.1017/S1041610296002657.

    CAS  Article  PubMed  Google Scholar 

  27. Melis RJF, Haaksma ML, Muniz-Terrera G. Understanding and predicting the longitudinal course of dementia. Curr Opin Psychiatry. 2019;32:123–9. https://doi.org/10.1097/YCO.0000000000000482.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Nunnally JC. Introduction to psychological measurement. New York: McGraw-Hill; 1970.

    Google Scholar 

  29. Eicher S, Theill N, Geschwindner H, Moor C, Wettstein A, Bieri-Brüning G, et al. The last phase of life with dementia in Swiss nursing homes: the study protocol of the longitudinal and prospective ZULIDAD study. BMC Palliat Care. 2016;15:80. https://doi.org/10.1186/s12904-016-0151-2.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Morris JN, Hawes C, Murphy K, Nonemaker S. Long-Term Care Resident Assessment Instrument user’s manual – version 2.0. Baltimore: Health Care Financing Administration. 1995.

    Google Scholar 

  31. Hartmaier SL, Sloane PD, Guess HA, Koch GG, Mitchell CM, Phillips CD. Validation of the Minimum Data Set Cognitive Performance Scale - agreement with the Mini-Mental-State-Examination. J Gerontol A Biol Sci Med Sci. 1995;50:M128–33. https://doi.org/10.1093/gerona/50a.2.m128.

    CAS  Article  PubMed  Google Scholar 

  32. Volicer L, Hurley AC, Blasi ZV. Scales for evaluation of end-of-life care in dementia. Alzheimer Dis Assoc Disord. 2001;15:194–200. https://doi.org/10.1097/00002093-200110000-00005.

    CAS  Article  PubMed  Google Scholar 

  33. Van der Steen JT, Volicer L. Family perceptions of wishes of dementia patients regarding end-of-life care. Int J Geriatr Psychiatry. 2011;26:214–20. https://doi.org/10.1002/gps.2542.

    Article  Google Scholar 

  34. Wessel S, Manthey M. Primary nursing. Person-centered care delivery system design. Minneapolis: Creative health care management; 2015.

    Google Scholar 

  35. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005;8:94–104. https://doi.org/10.1111/j.1524-4733.2005.04054.x.

    Article  PubMed  Google Scholar 

  36. DeVellis RF. Scale development: theory and applications. 4th ed. Los Angeles: Sage; 2017.

    Google Scholar 

  37. Terwee CB, Bot SDM, de Boer MR, van der Windt DAWM, Knol DL, Dekker J, et al. Quality criteria were proposed for mesurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42. https://doi.org/10.1016/j.jclinepi.2006.03.012.

    Article  PubMed  Google Scholar 

  38. de Vet HCW, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine: a practical guide. Cambridge: Cambridge University Press; 2011.

    Book  Google Scholar 

  39. Mokken RJ. A theory and procedure of scale analysis. Berlin: De Gruyter; 1971.

    Book  Google Scholar 

  40. Sijtsma K, Molenaar IW. Mokken models. In: van der Linden WJ, editor. Handbook of item response theory Volume 1: models. New York: Chapman and Hall; 2016. p. 303–21.

    Google Scholar 

  41. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63:737–45. https://doi.org/10.1016/j.jclinepi.2010.02.006.

    Article  PubMed  Google Scholar 

  42. StataCorp. Stata Statistical Software: Release 16.1. College Station: StataCorp LLC. 2019.

    Google Scholar 

  43. Krabbe PFM. The measurement of health and health status: concepts, methods and applications from a multidisciplinary perspective. Amsterdam: Elsevier; 2017.

    Book  Google Scholar 

  44. Kuder GF, Richardson MW. The theory and estimation of test reliability. Psychometrika. 1937;2:151–60. https://doi.org/10.1007/BF02288391.

    Article  Google Scholar 

  45. Yan X, Yang Y. RMSEA, CFI, and TLI in structural equation modeling with ordered categorical data: the story they tell depends on the estimation methods. Behav Res. 2019;51:409–28. https://doi.org/10.3758/s13428-018-1055-2.

    Article  Google Scholar 

  46. Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale: L. Erlbaum Associates; 1988.

    Google Scholar 

  47. Cassell EJ. Diagnosing suffering: a perspective. Ann Int Med. 1999;131:531–4. https://doi.org/10.7326/0003-4819-131-7-199910050-00009.

    CAS  Article  PubMed  Google Scholar 

  48. Agli O, Bailly N, Ferrand C. Spirituality and religion in older adults with dementia: a systematic review. Int Psychogeriatr. 2015;27:715–25. https://doi.org/10.1017/S1041610214001665.

    Article  PubMed  Google Scholar 

  49. Nunnally JC, Bernstein IH. Psychometric theory. New York: McGraw-Hill; 1994.

    Google Scholar 

  50. Chi I. Cross-cultural gerontology research methods: challenges and solutions. Ageing Soc. 2011;31:371–85. https://doi.org/10.1017/S0144686X10000942.

    Article  Google Scholar 

  51. Uniform Data System for Medical Rehabilitation, Center for Functional Assessment Research. Guide for the Uniform Data System for Medical Rehabilitation (Adult FIM), Version 4.0. Buffalo: State University of New York at Buffalo; 1993.

    Google Scholar 

  52. Raykov T, Marcoulides GA. Introduction to psychometric theory. New York: Routledge; 2011.

    Book  Google Scholar 

  53. Aminoff BZ. Aminoff Suffering Syndrome in Advanced Alzheimer’s Disease and End-of-Life: First 10 Years. Lett Health Biol Sci. 2017;2:86–90. https://doi.org/10.15436/2475-6245.17.021.

    Article  Google Scholar 

  54. MacLeod RD. Approach and nature of palliative care. In: MacLeod RD, Van den Block L, editors. Textbook of palliative care. Cham: Springer; 2019. p. 3–15.

    Chapter  Google Scholar 

  55. Beng TS, Ann YH, Guan NC, Chin LE, Loong LC, Ying NT, et al. The suffering pictogram: measuring suffering in palliative care. J Palliat Med. 2017;20:869–74. https://doi.org/10.1089/jpm.2016.0448.

    Article  PubMed  Google Scholar 

  56. Beng TS, Guan NC, Seang LK, Pathmawathi S, Ming MF, Jane LE, et al. The experiences of suffering of palliative care patients in Malaysia: a thematic analysis. Am J Hosp Palliat Care. 2014;31:45–56. https://doi.org/10.1177/1049909112458721.

    Article  PubMed  Google Scholar 

  57. van der Steen JT, Radbruch L, Hertogh CMPH, de Boer ME, Hughes JC, Larkin P, et al. White paper defining optimal palliative care in older people with dementia: A Delphi study and recommendations from the European Association for Palliative Care. Palliative Med. 2014;28:197–209. https://doi.org/10.1177/0269216313493685.

    Article  Google Scholar 

  58. Sawatzky R, Porterfield P, Lee J, Dixon D, Lounsbury K, Pesut B, et al. Conceptual foundations of a palliative approach: a knowledge synthesis. BMC Palliat Care. 2016;15:5. https://doi.org/10.1186/s12904-016-0076-9.

    Article  PubMed  PubMed Central  Google Scholar 

  59. de Forcrand C, Flannery M, Cho J, Reddy Pidatala N, Batra R, Booker-Vaughns J, et al. Pragmatic considerations in incorporating stakeholder engagement into a palliative care transitions study. Med care. 2021;59:S370–8. https://doi.org/10.1097/MLR.0000000000001583.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Federal Statistical Office (FSO). Active ageing. Neuchâtel: Federal Statistical Office (FSO). 2018.

    Google Scholar 

Download references

Acknowledgements

The authors thank the nursing home residents, their relatives, and primary nurses for participating in this project. They also thank Albert Wettstein for his support, and Christiane Arenz, Rebecca Billeter, Cecilia Câceda, Renate Fiedler, Silvia Seidl and Florian Koehn for data collection.

Funding

This study was funded by the Swiss National Science Foundation (grant 406740_139363) as part of the National Research Program 67 “End-of-life”. The City of Zurich Nursing Homes and the Sonnweid AG supported the ZULIDAD study.

Author information

Authors and Affiliations

Authors

Contributions

N.Z., K.Y., S.E., N.T., H.G., H.W., and F.R. conceived and designed the study and helped to draft the manuscript. S.E., N.T., and H.G. collected the data. N.Z. and K.Y. performed the statistical analysis. N.Z., K.Y., S.E., N.T., H.G., H.W., and F.R. revised the manuscript. All authors approved the submitted version of the manuscript. All authors agreed both to be personally accountable for the author's own contributions and to ensure that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature.

Corresponding author

Correspondence to Naomi Zumstein.

Ethics declarations

Ethics approval and consent to participate

The Ethics Committee of the Canton of Zurich approved the ZULIDAD study (Ref. KEK-ZH-Nr. 2013–0385). The primary nurses provided written informed consent prior to enrolment. Written informed consent for nursing home residents was obtained from legal guardians.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zumstein, N., Yamada, K., Eicher, S. et al. The German version of the Mini Suffering State Examination (MSSE) for people with advanced dementia living in nursing homes. BMC Geriatr 22, 595 (2022). https://doi.org/10.1186/s12877-022-03268-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12877-022-03268-0

Keywords

  • Advanced dementia
  • End-of-life care
  • Mini Suffering State Examination (MSSE)
  • Palliative care
  • Suffering
  • Validation